New York Presbyterian Brooklyn Methodist Hospital

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, New York Presbyterian Brooklyn Methodist Hospital sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 1 currently recruiting 6 completed later-stage tilt top decile by trial count

New York Presbyterian Brooklyn Methodist Hospital: 9 sponsored US clinical trials, 1 recruiting.

New York Presbyterian Brooklyn Methodist Hospital sponsors 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pain Control, with 1 trials.

Top-decile sponsor footprint

New York Presbyterian Brooklyn Methodist Hospital ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Where New York Presbyterian Brooklyn Methodist Hospital enrollment is open (later-stage tilt)

1 recruiting of 9 indexed (11% open); 6 completed (67%).

Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Pain Control (1 trial), 6 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

New York Presbyterian Brooklyn Methodist Hospital: open-pipeline peers nationwide

Peers matched on 9 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

New York Presbyterian Brooklyn Methodist Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%10%20%30%40%50% Total trials Recruiting share New York Presbyterian Brooklyn Methodist Hospital4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyADC Therapeutics S.A.Adrian VellaAIDS Malignancy ConsortiumAmylyx Pharmaceuticals
New York Presbyterian Brooklyn Methodist Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

New York Presbyterian Brooklyn Methodist Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this New York Presbyterian Brooklyn Methodist Hospital page

9 registered trials is a research-attention snapshot, not an endorsement of New York Presbyterian Brooklyn Methodist Hospital or any single study.

  • 1 of New York Presbyterian Brooklyn Methodist Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Pain Control is the condition New York Presbyterian Brooklyn Methodist Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pain Control trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

New York Presbyterian Brooklyn Methodist Hospital pipeline card: 9 registered trials from official public datasets.Report a data error.